Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

HPV infection is most commonly associated with cervical cancer, since roughly 99 per cent of all cervical cancer cases are connected to HPV. Nonetheless, experts warn that HPV is a virus that affects ...

The Union health ministry plans to introduce the HPV vaccine under the national immunisation programme, aiming to prevent ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

A scientist from Oaxaca in Mexico has made a breakthrough in medicine by completely eliminating the Human Papillomavirus (HPV ...

For the first time, Cuba is gearing up to integrate the human papillomavirus (HPV) vaccine into its National Immunization ...

HPV is responsible for more than 95% of cervical cancer cases in South Africa. If a high-risk HPV infection persists, it can ...

Currently, cervical cancer screens and HPV testing is recommended for women every 3 to 5 years starting ... The women ...

HPV self-sampling improves cervical cancer screening accessibility, offering comfort, privacy, and early detection for ...

This innovative approach will identify women with precancer and cancer in a single non-invasive test, having the potential to ...